-93G>A polymorphism of hMLH1 associated with prognosis for patients with colorectal cancer

被引：0
|
作者：
Kim, J. [1 ,2 ]
Chae, Y. [1 ,2 ]
Sohn, S. [1 ,2 ]
Kang, B. [1 ,2 ]
Lee, S. [1 ,2 ]
Lim, K. [1 ,2 ]
Choi, G. [1 ,2 ]
Baek, J. [1 ,2 ]
机构：
[1] Kyungpook Natl Univ, Taejon, South Korea
[2] Ulsan Univ Hosp, Ulsan, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4039
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MLH1-93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer
    Raptis, Stavroula
    Mrkonjic, Miralem
    Green, Roger C.
    Pethe, Vaijayanti V.
    Monga, Neerav
    Chan, Yuen Man
    Daftary, Darshana
    Dicks, Elizabeth
    Younghusband, Banfield H.
    Parfrey, Patrick S.
    Gallinger, Steven S.
    McLaughlin, John R.
    Knight, Julia A.
    Bapat, Bharati
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06): : 463 - 474
  • [22] MLH1-93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer
    Allan, James M.
    Shorto, Jennifer
    Adlard, Julian
    Bury, Jonathan
    Coggins, Ron
    George, Rina
    Katory, Mark
    Quirke, Philip
    Richman, Susan
    Scott, Daniel
    Scott, Kathryn
    Seymour, Matthew
    Travis, Lois B.
    Worrillow, Lisa J.
    Bishop, D. Timothy
    Cox, Angela
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (10) : 2456 - 2459
  • [23] Effect of MLH1-93G>A on gene expression in patients with colorectal cancer
    Funck, Alexandre
    Santos, Juliana C.
    Silva-Fernandes, Isabelle J. L.
    Rabenhorst, Silvia H. B.
    Martinez, Carlos A. R.
    Ribeiro, Marcelo L.
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 5
  • [24] Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer
    Wang, Yibaina
    Li, Dandan
    Li, Xia
    Teng, Chong
    Zhu, Lin
    Cui, Binbin
    Zhao, Yashuang
    Hu, Fulan
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [25] Predicting hMSH2 and hMLH1 mutations in colorectal cancer patients.
    Zong, JH
    Frazier, ML
    Etzel, CJ
    Levin, B
    Viscofsky, NA
    Lynch, PM
    Amos, CI
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1341S - 1341S
  • [26] Gender differences for Hmlh1 and P16 promoter methylation pattern and for hMLH1 protein loss in patients with MSI sporadic colorectal cancer
    Laghi, L
    Bianchi, P
    Destro, A
    Roncalli, M
    Malesci, A
    GASTROENTEROLOGY, 2003, 124 (04) : A365 - A365
  • [27] Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer
    Yibaina Wang
    Dandan Li
    Xia Li
    Chong Teng
    Lin Zhu
    Binbin Cui
    Yashuang Zhao
    Fulan Hu
    Medical Oncology, 2014, 31
  • [28] Evaluation of microsatellite instability, hmlh1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas: about 61 tunisians patients
    Ben Mahmoud, L.
    Arfaoui, A.
    Khiari, M.
    Chaar, I.
    Lounis, A.
    Dhraif, M.
    Abdellaoui, M.
    Gharbi, L.
    Mzabi, S.
    Bouraoui, S.
    HISTOPATHOLOGY, 2010, 57 : 97 - 97
  • [29] hMLH1 and hMSH2 immunostaining in colorectal cancer - Reply
    Talbot, I
    GUT, 2000, 47 (02) : 316 - 316
  • [30] hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients
    Kámory, E
    Kolacsek, O
    Ottó, S
    Csuka, O
    PATHOLOGY & ONCOLOGY RESEARCH, 2003, 9 (04) : 236 - 241
12345